GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    S. Karger AG ; 2010
    In:  Transfusion Medicine and Hemotherapy Vol. 37, No. 5 ( 2010), p. 299-305
    In: Transfusion Medicine and Hemotherapy, S. Karger AG, Vol. 37, No. 5 ( 2010), p. 299-305
    Type of Medium: Online Resource
    ISSN: 1660-3796 , 1660-3818
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2010
    detail.hit.zdb_id: 2100533-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Blood, American Society of Hematology, Vol. 112, No. 11 ( 2008-11-16), p. 1993-1993
    Abstract: Introduction: Safety of blood products today is mainly based on strict donor selection, screening systems to detect markers for transfusion relevant viruses and bacterial culturing. Window period, pathogens not tested, emerging viruses and slow growing bacteria are remaining risks for the recipient and will cause a failure of all safety measures. Pathogen inactivation will overcome those problems, at least for platelet and plasma units. UVC light without additional substances has recently proven to inactivate a broad range of viruses (with the exception of HIV) and bacteria (Fokke et al., Transfusion 2008). We investigated the influence of UVC irradiation on platelet storage parameters, apoptosis rate and aggregation capacity. In addition we visualized membrane integrity, mitochondrial activity and intra-platelet calcium content in living platelets using live confocal microscopy. Method: 12 double dose platelet concentrates (6.0x1011 platelets, WBC content below 106) were prepared by means of apheresis (Trima, Gambro BCT, USA), automatically suspended in platelet additive solution (SSP+, Macopharma, BRD) in a 60:40 ratio (SSP+ vs. plasma) and divided into two single units after a two hours resting period. One unit was UVC irradiated immediately after resting at a dose of 0.3J/cm2 (group 2), one remained untreated and both were stored at 22° C for 7 days (group 1). Storage parameters (glucose, lactate, LDH, pH) were analyzed before irradiation and on day two, five and seven. Apoptosis rate was calculated as the percentage of Annexin V positive cells within CD-41 pos cells. Combining life confocal imaging with three fluorescent dyes, fluorescent wheat germ agglutinin (WGA; Molecular Probes, Eugene, OR, USA), tetramethylrhodamine methyl ester perchlorate (TMRM; Sigma-Aldrich) and Rhod-2 (Molecular Probes) we assessed platelet morphology (WGA), mitochondrial activity (TMRM) and intra-platelet calcium (Rhod-2). A students paired T-test was used for statistical analysis and a p value of & lt; 0.05 was considered significant. Results: On day two, the only significant difference in the measured metabolic parameters could be seen in pH (7.28±0.04 vs. 7.25±0.05, group 1 vs. group2;p & lt; 0.01) and differences remained significant over the whole observation period (7.37±0.06 vs. 7.18±0.07, group 1 vs. group2;p & lt; 0.01). On day seven lactate values mg/dl (58.08±13.51 vs. 81.33±13.45, group 1 vs. group2; p & lt; 0.01) and glucose consumption mg/dl (80.33±19.49 vs. 59.50±16,97, group 1 vs. group2; p & lt; 0.01) reached statistical significance, only LDH (U/L) increase did not differ significantly between both groups even not on day seven (68.83±22.17 vs. 75.25±15.08 group 1 vs. group2; p= n.s.). Differences in aggregation capacity reach significance on day 5 (59.50%±10.45% vs. 55.92%±12.30%, group 1 vs. group2; p & lt; 0.05) but not on day seven. Rate of apoptotic platelets was similar on day 2, reaches significance on day 5 (6.53%±3.02% vs. 8.52±3.53, group 1 vs. group2; p & lt; 0.01) and increased on day seven (9.98%±7.34% vs. 18.89%±14.96%, group 1 vs. group2 ; p & lt; 0.01). Image analysis of the confocal data comparing paired samples from untreated and UVC treated platelets revealed no significant differences for all time points. Neither mitochondrial activity, intra platelet calcium content, platelet morphology nor platelet membrane integrity differed between the compared samples. Conclusion: Influence of UVC irradiation of platelet concentrates as a pathogen inactivation method could be witnessed in metabolic parameters as well as in a decrease of aggregation capability and an increase in the rate of apoptotic cells after seven days in a paired comparison with untreated platelets. However differences are small and the total values of the measured parameters meet the quality requirements for platelets. Live confocal imaging of living platelets supports our conclusion but further recovery and survival studies with UVC treated platelets are necessary to compare in-vitro data with in-vivo data.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2008
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2010
    In:  Cancer Research Vol. 70, No. 23 ( 2010-12-01), p. 9611-9620
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 70, No. 23 ( 2010-12-01), p. 9611-9620
    Abstract: Statins are inhibitors of cholesterol biosynthesis and protein prenylation that also have been studied in cancer therapy and chemoprevention. With regard to natural killer (NK) cells, only inhibitory effects of statins such as suppression of granule exocytosis have been reported so far. In this study, we show that statins can cooperate with IL-2 to potently induce the activation of CD56dim NK cells in a synergistic, time- and dose-dependent fashion. Supplementation experiments revealed that the statin effect was specific to inhibition of their target hydroxymethylglutaryl coenzyme A reductase and that downstream depletion of geranylgeranyl pyrophosphate was responsible for cooperating with IL-2 in NK cell activation. Mechanistic studies revealed that CD56+HLA-DR+CD14+ dendritic cell (DC)-like accessory cells mediated the ability of statin to activate NK cells. In contrast, BDCA-1+ (CD1c+) myeloid DCs, which partially expressed CD56, were somewhat less potent. Conventional blood monocytes, which lack CD56, exhibited the lowest accessory cell capacity. NK cell IFN-γ production was IL-12 independent but required endogenous IL-18, IL-1β, and caspase-1 activity. Statins directly induced apoptosis in human cancer cell lines and cooperated with NK cell–derived IFN-γ to generate potent cytotoxic antitumor effects in vitro even in the presence of statin-mediated inhibitory effects on granule exocytosis. Our work reveals novel and unexpected immunomodulatory properties of statins, which might be harnessed for the treatment of cancer. Cancer Res; 70(23); 9611–20. ©2010 AACR.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2010
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 1997
    In:  Nature Vol. 387, No. S6632 ( 1997-05-29), p. 5-5
    In: Nature, Springer Science and Business Media LLC, Vol. 387, No. S6632 ( 1997-05-29), p. 5-5
    Type of Medium: Online Resource
    ISSN: 0028-0836 , 1476-4687
    RVK:
    RVK:
    RVK:
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 1997
    detail.hit.zdb_id: 120714-3
    detail.hit.zdb_id: 1413423-8
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Elsevier BV ; 2016
    In:  Cell Reports Vol. 16, No. 2 ( 2016-07), p. 444-456
    In: Cell Reports, Elsevier BV, Vol. 16, No. 2 ( 2016-07), p. 444-456
    Type of Medium: Online Resource
    ISSN: 2211-1247
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2016
    detail.hit.zdb_id: 2649101-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Nature Immunology, Springer Science and Business Media LLC, Vol. 19, No. 12 ( 2018-12), p. 1352-1365
    Type of Medium: Online Resource
    ISSN: 1529-2908 , 1529-2916
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2018
    detail.hit.zdb_id: 2026412-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    IOS Press ; 1985
    In:  Human Systems Management Vol. 5, No. 4 ( 1985-12-01), p. 323-331
    In: Human Systems Management, IOS Press, Vol. 5, No. 4 ( 1985-12-01), p. 323-331
    Abstract: As organizations adapt to changes in technology, the management systems of the organization change. The organization design and job designs change, moving toward a more hierarchic organization design with simplified, routine jobs requiring less responsibility and learning, or toward a more professional organization design with technical or professional knowledge acquisition, or toward a more entrepreneurial organization design with individual autonomy in goal setting and achievement, or toward a more group oriented organization design where responsibility and learning are shared to enhance performance. As these changes occur, the performance appraisal and reward systems of organizations adapt to suit the unique needs of the new organization and job designs. This study indicates that the four work designs require different performance criteria, unique measures of performance, appropriate communication processes, and congruent forms and procedures.
    Type of Medium: Online Resource
    ISSN: 1875-8703 , 0167-2533
    Language: Unknown
    Publisher: IOS Press
    Publication Date: 1985
    detail.hit.zdb_id: 2010609-9
    SSG: 3,2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: The Lancet, Elsevier BV, Vol. 387 ( 2016-02), p. S108-
    Type of Medium: Online Resource
    ISSN: 0140-6736
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2016
    detail.hit.zdb_id: 2067452-1
    detail.hit.zdb_id: 3306-6
    detail.hit.zdb_id: 1476593-7
    SSG: 5,21
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 82, No. 12_Supplement ( 2022-06-15), p. 2851-2851
    Abstract: Chimeric antigen receptor (CAR) modification of αβ T cells has revolutionized the field of oncology, driving the focus of attention to the immune system to target and fight malignancies. Currently available αβ T-cell therapies come with many challenges, including alloreactivity, off-target toxicities, cytokine release syndrome, limited survival of infused cells and the necessity to gene edit cells to overcome graft vs. host disease. Whilst some of these limitations can be overcome with complex and costly gene-engineering approaches, utilizing innate immune cells which are inherently non-HMC restricted and able to orchestrate wider immune responses might provide an alternative strategy avoiding many of these obstacles. Many groups developed protocols to grow and modify natural killer cells and invariant natural killer T-cells whilst others, including ours, focused on the development of Vδ1 γδ T-cell-based immunotherapies. Currently, these cell types are evaluated in the clinic in both non-engineered and engineered versions. Most of these engineering principles have been directly translated from the αβ CAR-T field without taking into consideration the biology of innate immune cells: they utilize αβ T-cell specific co-stimulatory molecules and signaling cassettes as well as armoring strategies developed for αβ T-cells. Vδ1 T-cells are tissue resident lymphocytes, which for most of their lifetime remain in epithelia rich tissues. They consistently survey tissues and monitor malignant transformation using a variety of natural cytotoxicity receptors, NK like receptors and the γδ TCR. In contrast to αβ T-cells, Vδ1 T-cells do not follow the ‘two-signal theory’: they must integrate multiple signals from an array of receptors in order to discriminate between healthy and malignant cells. We thus propose that CAR strategies exclusively utilizing CD3ζ activation domains are not using the full potential of innate immune cells for cellular immunotherapy. Another distinguishing feature of Vδ1 T-cells is the absence of traditional autocrine cytokine feedback loops seen in αβ T-cells. Our results demonstrate that traditional cytokine armoring strategies utilizing forced secretion of soluble or membrane-tethered IL-15 are detrimental to the biology of Vδ1 T-cells. By dissecting the IL-15 receptor biology we are now able to create cells that not only survive and grow in the absence of exogenous IL-15 but become more sensitive to endogenous levels. Applying γδ T-cell biology and an adapted understanding of the IL-15 pathway, we have now created novel engineering strategies to tailor specificity, potency, and proliferation of Vδ1 T-cells even in the presence of CAR whilst maintaining the cells’ inherent ability to discriminate between healthy and malignant cells. Preclinical evaluation of these concepts is ongoing with the aim to develop next generation tailored Vδ1T-cell immunotherapies. Citation Format: Jyothi Kumaran, Rajeev Karattil, André Simoes, Rebecca Alade, Mihil Patel, Liz Wood, Gonzalo Mercado Vico, Amy Lane, Sara Tamagno, Sarah Edwards, Andrea Venuso, Sam Illingworth, Alice Brown, Michael Koslowski, Istvan Kovacs, Oliver Nussbaumer. Moving on: Embracing γδ T-cell biology to create truly next generation immunotherapy concepts [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2851.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2022
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    The American Association of Immunologists ; 2013
    In:  The Journal of Immunology Vol. 191, No. 3 ( 2013-08-01), p. 1346-1355
    In: The Journal of Immunology, The American Association of Immunologists, Vol. 191, No. 3 ( 2013-08-01), p. 1346-1355
    Abstract: The potent nitrogen-containing bisphosphonate zoledronate inhibits farnesyl pyrophosphate synthase, a key enzyme of the mevalonate pathway that is often hyperactive in malignant cells. Zoledronate activates human Vγ9Vδ2 T cells, which are immune sentinels of cell stress and tumors, through upstream accumulation of the cognate Ag isopentenyl pyrophosphate. IL-18 was shown to enhance zoledronate-induced γδ T cell activation. Although monocytes have been considered important accessory cells that provide the Ag isopentenyl pyrophosphate, CD56brightCD11c+ NK cells were postulated to mediate the costimulatory effects of IL-18. We report in this article that downstream depletion of geranylgeranyl pyrophosphate (GGPP), which is required for protein prenylation, caused cell stress in monocytes, followed by caspase-1–mediated maturation and release of IL-18, which, in turn, induced γδ T cell CCL2. Likewise, zoledronate caused a substantial delay in γδ T cell expansion, which could be skipped by GGPP supplementation. Moreover, repletion of GGPP, which prevented acute zoledronate toxicity, and supplementation with IL-18, which strongly upregulated IL-2Rα (CD25) and favored the central memory phenotype, were sufficient to enable zoledronate-induced expansion of highly purified γδ T cells, even when starting cell numbers were as low as 104 γδ T cells. Our study reveals essential components of γδ T cell activation and indicates that exogenous IL-18, which can directly costimulate γδ T cells, eliminates the need for any accessory cells. Our findings will facilitate the generation of robust γδ T cells from small blood or tissue samples for cancer immunotherapy and immune-monitoring purposes.
    Type of Medium: Online Resource
    ISSN: 0022-1767 , 1550-6606
    RVK:
    RVK:
    Language: English
    Publisher: The American Association of Immunologists
    Publication Date: 2013
    detail.hit.zdb_id: 1475085-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...